BRIEF published on 06/09/2026 at 08:05, 5 months 3 days ago Les acteurs du secteur unis pour la sensibilisation à la maladie de Batten Partenariat Étude Clinique Maladie De Batten Sensibilisation THX Pharma
BRIEF published on 06/09/2026 at 08:05, 5 months 3 days ago Industry stakeholders united to raise awareness of Batten disease Partnership Clinical Study Awareness Batten Disease THX Pharma
BRIEF published on 06/09/2026 at 08:04, 5 months 3 days ago Molten Ventures Reports £238m Valuation Uplift Following ICEYE Series F Financing Satellite Technology Molten Ventures Valuation Uplift ICEYE Series F European Tech Investment
BRIEF published on 06/09/2026 at 08:04, 5 months 3 days ago Molten Ventures annonce une valorisation revue à la hausse de 238 millions de livres sterling suite à son financement de série F par ICEYE. Molten Ventures Technologie Satellitaire Revalorisation Série ICEYE F Investissements Technologiques Européens
BRIEF published on 06/09/2026 at 08:00, 5 months 3 days ago Fireaway Receives Certifications for Stat-X Fire-Extinguishing Systems Type Approval Bureau Veritas Stat-X Systems SOLAS Compliance Marine Certification
BRIEF published on 06/09/2026 at 08:00, 5 months 3 days ago Fireaway obtient les certifications pour ses systèmes d'extinction d'incendie Stat-X Homologation De Type Bureau Veritas Systèmes Stat-X Conformité SOLAS Certification Maritime
BRIEF published on 06/09/2026 at 07:54, 5 months 3 days ago K+S Aktiengesellschaft Unveils €300 Million Convertible Bonds Offering Convertible Bonds Institutional Investors K+S Aktiengesellschaft Bond Redemption Salt Business Acquisition
BRIEF published on 06/09/2026 at 07:54, 5 months 3 days ago K+S Aktiengesellschaft dévoile une offre d'obligations convertibles de 300 millions d'euros Obligations Convertibles Investisseurs Institutionnels Rachat D'obligations K+S Aktiengesellschaft Acquisition De Salt Business
BRIEF published on 06/09/2026 at 07:50, 5 months 3 days ago Pentixapharm Holding AG Advances with FDA Approval and Capital Increase Plan FDA Approval Capital Increase Primary Aldosteronism PANDA Study BaFin Review
BRIEF published on 06/09/2026 at 07:50, 5 months 3 days ago Pentixapharm Holding AG franchit une étape importante avec l'approbation de la FDA et son plan d'augmentation de capital Augmentation De Capital Approbation De La FDA Aldostéronisme Primaire Étude PANDA Revue De La BaFin
Published on 11/12/2026 at 15:55, 2 hours 17 minutes ago DIAGENS Leads in Two Major Global AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets, Ushering in a New Era for Medical Imaging AI
Published on 11/12/2026 at 14:31, 3 hours 41 minutes ago First Breach Inc. Announces Third Quarter 2026 Earnings Conference Call
Published on 11/12/2026 at 14:00, 4 hours 12 minutes ago GameSquare Announces Peaky Blinders Digital Fan Experience, Advancing the Company's IP Monetization Strategy
Published on 11/12/2026 at 14:00, 4 hours 12 minutes ago NuRAN Wireless Highlights Recurring Revenue Economics and Growth Potential of Its 5,092-Tower Contracted NaaS Portfolio
Published on 11/12/2026 at 13:45, 4 hours 27 minutes ago Amarc and Freeport Successfully Complete 2026 Joy Copper-Gold District Exploration Program
Published on 11/12/2026 at 18:00, 12 minutes ago E-PANGO: Report de l’audience du 9 novembre 2026 Devant le Tribunal des activités économiques de Paris
Published on 11/12/2026 at 17:53, 19 minutes ago Brockhaus Technologies AG: 9M 2026 revenue of €20.0 million and adjusted EBITDA of €-1.0 million; revenue and adjusted EBITDA for 2026 expected at the lower end of the forecast
Published on 11/12/2026 at 17:45, 27 minutes ago Intershop disposes its fully developed Lehenmatt properties in Basel
Published on 11/12/2026 at 17:45, 27 minutes ago CTS EVENTIM generates further profitable growth in the first nine months of 2026
Published on 11/12/2026 at 18:00, 12 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 18:00, 12 minutes ago Chiffre d’affaires du 1er semestre 2026-27 : 45,6 M€
Published on 11/12/2026 at 18:00, 12 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 12 novembre 2026
Published on 11/12/2026 at 17:40, 32 minutes ago Financial information for the period ended 30 September 2026
